Portolan Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.06M Sell
89,274
-12,372
-12% -$1.05M 0.3% 93
2026
Q1
$8.49M Buy
+101,646
New +$8.34M 0.45% 66
2023
Q4
Sell
-65,363
Closed -$4.77M 144
2023
Q3
$4.77M Buy
+65,363
New +$4.42M 0.45% 72
2023
Q2
Sell
-124,051
Closed -$7.28M 144
2023
Q1
$7.28M Buy
+124,051
New +$7.53M 0.69% 51
2022
Q4
Sell
-58,206
Closed -$3.91M 144
2022
Q3
$3.91M Sell
58,206
-63,030
-52% -$3.99M 0.41% 87
2022
Q2
$7.44M Sell
121,236
-7,025
-5% -$450K 0.75% 53
2022
Q1
$8.65M Buy
+128,261
New +$6.93M 0.69% 60

Other funds holding HQY

Portolan Capital Management's HQY Position: Q2 2026 in Review

Portolan Capital Management reduced its HealthEquity (HQY) stake by 12% in Q2 2026, selling an estimated $1.05M and leaving 89,274 shares worth $8.06M. The position accounts for 0.3% of the portfolio, ranked #93.

Portolan Capital Management first reported a position in HQY in Q1 2022 and has held it in 7 quarters since. The position peaked at $8.65M in Q1 2022. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Portolan Capital Management held 89,274 shares of HealthEquity worth $8.06M as of Q2 2026.
  • Portolan Capital Management sold 12,372 HealthEquity shares in Q2 2026, an estimated $1.05M.
  • HealthEquity made up 0.3% of Portolan Capital Management's portfolio in Q2 2026, its #93 holding.
  • Portolan Capital Management first reported a position in HealthEquity in Q1 2022 and has held it in 7 quarters since.
  • Portolan Capital Management's HealthEquity position peaked at $8.65M in Q1 2022.
  • 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Portolan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.